These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


675 related items for PubMed ID: 19381408

  • 1. Influence of amine ligands on the aquation and cytotoxicity of trans-diamine platinum(II) anticancer complexes.
    Cubo L, Quiroga AG, Zhang J, Thomas DS, Carnero A, Navarro-Ranninger C, Berners-Price SJ.
    Dalton Trans; 2009 May 14; (18):3457-66. PubMed ID: 19381408
    [Abstract] [Full Text] [Related]

  • 2. Solution behaviour and biomolecular interactions of two cytotoxic trans-platinum(II) complexes bearing aliphatic amine ligands.
    Cubo L, Casini A, Gabbiani C, Mastrobuoni G, Messori L, Jiménez-Barbero J, Navarro-Ranninger C, Quiroga AG.
    Chemistry; 2009 Sep 14; 15(36):9139-46. PubMed ID: 19655350
    [Abstract] [Full Text] [Related]

  • 3. Contrasting chemistry of cis- and trans-platinum(II) diamine anticancer compounds: hydrolysis studies of picoline complexes.
    McGowan G, Parsons S, Sadler PJ.
    Inorg Chem; 2005 Oct 17; 44(21):7459-67. PubMed ID: 16212372
    [Abstract] [Full Text] [Related]

  • 4. [1H, 15N] heteronuclear single quantum coherence NMR study of the mechanism of aquation of platinum(IV) ammine complexes.
    Davies MS, Hall MD, Berners-Price SJ, Hambley TW.
    Inorg Chem; 2008 Sep 01; 47(17):7673-80. PubMed ID: 18671390
    [Abstract] [Full Text] [Related]

  • 5. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.
    Komeda S, Kalayda GV, Lutz M, Spek AL, Yamanaka Y, Sato T, Chikuma M, Reedijk J.
    J Med Chem; 2003 Mar 27; 46(7):1210-9. PubMed ID: 12646031
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Three new asymmetric trans-amine(azole)dichloridoplatinum complexes that overcome cisplatin resistance and their reactions with 5'-GMP.
    Pantoja E, Gallipoli A, van Zutphen S, Komeda S, Reddy D, Jaganyi D, Lutz M, Tooke DM, Spek AL, Navarro-Ranninger C, Reedijk J.
    J Inorg Biochem; 2006 Dec 27; 100(12):1955-64. PubMed ID: 17083978
    [Abstract] [Full Text] [Related]

  • 9. Synthesis, X-ray crystallographic, and NMR characterizations of platinum(II) and platinum(IV) pyrophosphato complexes.
    Mishur RJ, Zheng C, Gilbert TM, Bose RN.
    Inorg Chem; 2008 Sep 15; 47(18):7972-82. PubMed ID: 18693681
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Chloro half-sandwich osmium(II) complexes: influence of chelated N,N-ligands on hydrolysis, guanine binding, and cytotoxicity.
    Peacock AF, Habtemariam A, Moggach SA, Prescimone A, Parsons S, Sadler PJ.
    Inorg Chem; 2007 May 14; 46(10):4049-59. PubMed ID: 17441712
    [Abstract] [Full Text] [Related]

  • 12. Fluorescent analogues of quinoline reveal amine ligand loss from cis and trans platinum(II) complexes in cancer cells.
    New EJ, Roche C, Madawala R, Zhang JZ, Hambley TW.
    J Inorg Biochem; 2009 Aug 14; 103(8):1120-5. PubMed ID: 19564043
    [Abstract] [Full Text] [Related]

  • 13. Synthesis, structure, and reactivity of monofunctional platinum(II) and palladium(II) complexes containing the sterically hindered ligand 6-(methylpyridin-2-yl)acetate.
    Ma Y, Day CS, Bierbach U.
    J Inorg Biochem; 2005 Oct 14; 99(10):2013-23. PubMed ID: 16087242
    [Abstract] [Full Text] [Related]

  • 14. Design, synthesis, characterisation and chemical reactivity of mixed-ligand platinum(II) oxadiazoline complexes with potential cytotoxic properties.
    Wagner G, Marchant A, Sayer J.
    Dalton Trans; 2010 Sep 07; 39(33):7747-59. PubMed ID: 20657943
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cationic nonsymmetric transplatinum complexes with piperidinopiperidine ligands. Preparation, characterization, in vitro cytotoxicity, in vivo toxicity, and anticancer efficacy studies.
    Najajreh Y, Khazanov E, Jawbry S, Ardeli-Tzaraf Y, Perez JM, Kasparkova J, Brabec V, Barenholz Y, Gibson D.
    J Med Chem; 2006 Jul 27; 49(15):4665-73. PubMed ID: 16854072
    [Abstract] [Full Text] [Related]

  • 17. Kinetic and mechanistic study of the Pt(II) versus Pt(IV) effect in the platinum-mediated nitrile-hydroxylamine coupling.
    Luzyanin KV, Kukushkin VY, Ryabov AD, Haukka M, Pombeiro AJ.
    Inorg Chem; 2005 Apr 18; 44(8):2944-53. PubMed ID: 15819582
    [Abstract] [Full Text] [Related]

  • 18. Synthetic, structural and biochemical studies of polynuclear platinum(II) complexes with heterocyclic ligands.
    Rubino S, Portanova P, Girasolo A, Calvaruso G, Orecchio S, Stocco GC.
    Eur J Med Chem; 2009 Mar 18; 44(3):1041-8. PubMed ID: 18676063
    [Abstract] [Full Text] [Related]

  • 19. In vitro cytotoxicity study on platinum (II) complexes with epoxysuccinates as leaving groups.
    Liu X, Shen H, Zhu H, Cui K, Gou S.
    Bioorg Med Chem Lett; 2007 Jul 15; 17(14):3831-4. PubMed ID: 17533124
    [Abstract] [Full Text] [Related]

  • 20. Preparation of platinum(IV) complexes with dipeptide and diimine. X-ray crystal structure and 195Pt NMR spectra.
    Watabe M, Fukuda H, Kitsukawa K, Nakajima H, Yukawa Y, Igarashi S, Fujii Y, Takayama T.
    J Inorg Biochem; 2006 Oct 15; 100(10):1653-9. PubMed ID: 16857262
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 34.